A case report of a fetus that presented at 33 weeks gestation with profound bradycardia associated with ventricular rates of <50 beats per minute. Possible management strategies include continued observation, medical intervention of the mother with stimulants and urgent delivery of the fetus. The differential diagnosis, management and ultimate course of this patient are discussed.
INTRODUCTION
Fetal bradycardia presents a difficult differential diagnosis associated with multiple potential therapeutic strategies for the perinatologist. If a fetus shows signs of hydrops fetalis, urgent delivery maybe warranted; however, if a fetus is stable, without signs of fetal distress, the medical management requires one to postulate the cause of bradycardia, risk of fetal demise and optimal treatment of the mother or fetus. The differential diagnosis of fetal bradycardia includes sinus bradycardia, blocked premature atrial contractions, variable second-degree AV block and complete heart block. Fetal echocardiography provides a reasonable level of comfort when differentiating between these causes of bradycardia. This limits the differential diagnosis and allows one to postulate different therapeutic strategies. There is a growing body of evidence that the autoimmune form of congenital heart block may have a progressive nature 1 and there are several reports of successful treatment of intrauterine heart block with corticosteroids in order to prevent the progression of heart block in utero. [2] [3] [4] [5] [6] [7] [8] Also reported is determination of autoimmune-associated heart block by obtaining maternal antibody titers to either SS-A/Ro or SS-B/La antibodies prior to making a therapeutic decision. 1 Stimulants administered intravenously or orally to the mother have been used to increase the baseline heart rate in a fetus with heart block in order to allow the baby to mature in utero and defer delivery until later in gestation. [8] [9] [10] CASE REPORT J.C. was a 35-year-old gravida IV, para III female. Her initial referral to pediatric cardiology was at 32 weeks gestation for fetal arrhythmia. Her pregnancy had been complicated by gestational diabetes. The ultrasound at initial evaluation documented multiple ventricular septal defects in addition to the fetal arrhythmia. Fetal echocardiography demonstrated atrial and ventricular premature contractions with intermittent AV block. The overall heart rate remained above 100 beats per minute (bpm) ( Figure 1 ) and a repeat evaluation was scheduled for one week's time. The follow-up study at about 33 weeks gestation revealed 2:1 AV block with a resultant ventricular rate of 60 bpm. The mother was admitted for observation and was given steroids in anticipation of early delivery. After 2 days in the hospital, repeat fetal ultrasound documented an atrial rate of 85 to 96 bpm with a resultant ventricular rate of 42 to 48 bpm and abnormal umbilical artery Doppler (Figures 2a and b) . Owing to the rapid change in cardiac rhythm and potential for imminent fetal demise because of extreme bradycardia with low ventricular and atrial rates, a decision was made to emergently deliver the fetus. Maternal anti-SSA/Ro and anti-SSB/La antibodies were sent; however, the results were not immediately available. Prior to undergoing anesthesia for the delivery, the mother had an electrocardiogram, which was normal including the QTc interval. The differential diagnosis at the time of delivery included autoimmune-mediated heart block, long QTc syndrome with heart block, fetal distress and acute myocarditis with primary conduction system involvement.
The baby was born by Cesarean section and had Apgar scores of 3 and 6 at 1 and 5 minutes, respectively. The patient was brought immediately to the intensive-care nursery. The initial electrocardiogram revealed a normal sinus rhythm at a rate of 110 bpm with QTc of 615 ms (normal <440 ms) (Figure 3 ). The echocardiogram confirmed multiple midmuscular ventricular septal defects of small size. The baby was intubated and received supplementary oxygen and beractant intratracheal suspension (Survanta) for treatment of infant respiratory distress syndrome. The initial electrolytes revealed magnesium of 2.0 mg/dl and calcium of 7.9 mg/dl. The respiratory status improved rapidly and the baby was extubated on the second day of life. During the first day of life, the patient developed variable AV block and frequent ventricular ectopy (Figure 4) . The patient was given magnesium sulfate and referred for pacemaker placement. Since that time, he has been followed expectantly on beta-blockade therapy combined with ventricular pacing. He is growing and thriving at 18 months of age.
DISCUSSION
Complete heart block or extremes of second-degree AV block provide a dilemma not only in the diagnosis but also in the management of such fetuses. It is well documented that there is an increased risk of fetal demise with heart rates r55 bpm. 11 Treatment strategies have included maternal administration of stimulants [8] [9] [10] in order to increase the fetal heart rate; however, complications from this type of approach include but are not limited to maternal arrhythmia, pulmonary edema, hypertension, tremors and jitteriness. An as yet unreported complication would be the inadvertent use of a stimulant in a fetus with bradycardia associated with the long QTc syndrome. Stimulants, sympathomimetic agents and other drugs that cause prolongation In general, documenting the presence of maternal anti-SSA/Ro and anti-SSB/La antibodies would be reassuring that one were dealing with an autoimmune-associated heart block in utero. This would then allow safe medical therapy with maternal steroids and stimulants. However, as in our reported case, in the absence of confirmatory antibody titers, the use of stimulants in fetal bradycardia may not be prudent.
In the event of complete or variable fetal heart block, we suggest obtaining electrocardiograms on the mother and father to screen for long QT syndrome. In our case report, paternal testing could not be performed, nor was a family history available on the paternal side. Maternal family history was negative for sudden cardiac death, recurrent syncope and congenital deafness. It is important to note that up to one-third of congenital long QT syndrome cases are sporadic and some families have penetrance rates as low as 25%. 12 Therefore, absence of electrocardiographic criteria for long QT syndrome in first-degree relatives does not exclude this diagnosis in the fetus. Postnatal electrocardiography is the current gold standard for diagnosis. In cases where long QT syndrome is high on the differential diagnosis, such as those with sinus bradycardia, family history positive for long QT syndrome and the combination of second-degree AV block and ventricular arrhythmias, 13 maternal administration of medications known to prolong the QTc interval 14 should be avoided. There are many challenges in the diagnosis and treatment of fetal bradycardia. Diagnostic challenges include the assessment of fetal well being and accurate fetal echocardiography to document the cardiac anatomy, type of arrhythmia and presence of heart failure. Treatment options include maternal steroids, maternal stimulants and early delivery. Consideration must be given to the possibility of long QT syndrome and potential contraindication of stimulants in this subgroup of patients. Since both transvenous and transcutaneous pacing are available for neonates and premature infants, [15] [16] [17] [18] early delivery with immediate pacing may be safer than subjecting a fetus to a medication that may provoke lifethreatening arrhythmias. One may consider the use of stimulants, if maternal anti-SSA/Ro and anti-SSB/La antibodies are documented and both parents of the fetus have no electrocardiographic findings or clinical history suggestive of long QT syndrome.
